Published April 28, 2026 | Version v1

PARP1 Inhibition for Progeria-Associated DNA Damage

  • 1. MedicOath

Description

PARP1 is hyperactivated in progeria due to persistent DNA damage from progerin-induced nuclear dysfunction, leading to NAD+ depletion and cellular energetic crisis. PARP1 inhibitors like olaparib reduce poly(ADP-ribose) synthesis, preserve cellular NAD+ pools, and prevent PARP1-mediated cell death pathways.

Notes

IPFS: QmV2pBNks4KcXLWoK8FTdAU1cqgoVWic42A1ECdaJxDbUN. TX: 0x221ab03d1f1f5d647a206e9f14ed7b607fc1d44b94324c6ccab479d173021213. CC0.

Files

hypothesis.json

Files (312 Bytes)

Name Size Download all
md5:4461633a7025cc20b2f9e4bc0021dd40
312 Bytes Preview Download